TY - JOUR
T1 - Induced humoral immunity and vaccination against major human fungal pathogens
AU - Casadevall, Arturo
AU - Feldmesser, Marta
AU - Pirofski, Liise Anne
PY - 2002
Y1 - 2002
N2 - Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.
AB - Protection against fungal pathogens can theoretically be elicited by vaccines that stimulate humoral or cellular immunity, or both. There is conclusive evidence that humoral immunity can modify the course of infection against certain pathogenic fungi such as Candida albicans and Cryptococcus neoformans. However, for other fungi, such as Aspergillus fumigatus, the notion that humoral immunity contributes to host defence is unproven. Attempts to evaluate the potential efficacy of humoral immunity using immune sera are often inconclusive, whereas consistent results can be obtained with monoclonal antibodies. Protective monoclonal antibodies can be used to identify antigens that induce useful humoral responses.
UR - http://www.scopus.com/inward/record.url?scp=0036345760&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036345760&partnerID=8YFLogxK
U2 - 10.1016/S1369-5274(02)00337-5
DO - 10.1016/S1369-5274(02)00337-5
M3 - Review article
C2 - 12160857
AN - SCOPUS:0036345760
SN - 1369-5274
VL - 5
SP - 386
EP - 391
JO - Current Opinion in Microbiology
JF - Current Opinion in Microbiology
IS - 4
ER -